Valganciclovir Tablet

Get a Price/Quote

MOQ : 500 Boxes

Valganciclovir Tablet Specification

Grade
Pharmaceutical Grade

Molecular Formula
C14H22N6O5

Purity
Approximately 99%

CAS No
175865-59-5

Application
Hospital, Clinical

Formulations Type
General Drugs

Formulations Form
Tablets

Treatments & Functions
Used for treatment of cytomegalovirus (CMV) infection in immunocompromised patients

Gender/Age Group
Suitable for Adults

Dosage Guidelines
As described by physician, typically 450mg or 900mg once or twice daily

Volume
Available in 450 mg per tablet

Storage Instructions
Dry Place

Valganciclovir Tablet Trade Information

Minimum Order Quantity
500 Boxes

FOB Port
Mundra Port

Supply Ability
10000 Boxes Box Per Month

Delivery Time
30 Days

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
As Per buyer Requirements

Main Export Market(s)
Australia, North America, Eastern Europe, Africa, Central America, Middle East, South America, Western Europe, Asia

Main Domestic Market
All India

Certifications
ISO, GMP, WHO, FDA

About Valganciclovir Tablet

Valganciclovir Tablet

Product Description
Counted among the leading entities, we are successfully exporting Valganciclovir Tab. The medicine is recommended for the treatment for cytomegalovirus (CMV) infection of the eye. This is prescribed for the patients who have acquired immunodeficiency syndrome (AIDS). An antiviral agent, this Valganciclovir Tab works by stopping the multiplication and growth of virus. We are offering these medicines to clients at highly competitive prices.

Key points: Used to prevent CMV disease in patients who have undergone transplantation of heart and kidney-pancreas

Brand : Valgan
Contain : Valganciclovir Tab
Strength : 500mg
Packing : Strip

Mechanism of Action and Benefits

Valganciclovir acts by inhibiting the replication of cytomegalovirus (CMV), making it effective in treating and preventing infections in immunocompromised patients. Its targeted antiviral activity significantly reduces the risk of CMV-related complications, promoting better health outcomes and recovery.

Usage and Dosage Guidelines

The tablet should be taken orally, following your physicians prescribed dosagetypically 450mg or 900mg, once or twice daily depending on infection severity and patient profile. Consistent administration as instructed is crucial to maximize therapeutic benefits and suppress viral activity.

Storage and Safety Information

Keep Valganciclovir Tablets in a dry place, away from direct sunlight. Adherence to storage recommendations maintains the tablets efficacy. The medication should not be used during pregnancy, lactation, or in children unless specifically directed by a healthcare provider. Prescription-only use ensures safety.

FAQs of Valganciclovir Tablet:

Q: How should I take Valganciclovir Tablets for best results?

A: Valganciclovir Tablets should be taken orally, exactly as prescribed by your physician. Swallow the tablet whole with water, without crushing or chewing, preferably at the same time daily to maintain proper blood levels and maximize effectiveness.

Q: What conditions are treated with Valganciclovir Tablets?

A: These tablets are mainly used for the treatment and prevention of cytomegalovirus (CMV) infection, predominantly in immunocompromised adults, such as transplant recipients or those with weakened immune systems.

Q: When should Valganciclovir be avoided?

A: Valganciclovir should not be used during pregnancy, lactation, or in children unless specifically advised by a healthcare professional, due to potential risks. Discuss any specific medical conditions or ongoing treatments with your physician before use.

Q: Where should I store Valganciclovir Tablets?

A: Store the tablets in a dry area at room temperature, away from moisture and direct sunlight. Keep them out of reach of children and only use within the indicated shelf life of 24 months.

Q: What is the advantage of using Valganciclovir for CMV infection?

A: Valganciclovir offers potent antiviral coverage specifically against CMV, helping to prevent severe complications in at-risk populations. Its oral form provides convenience without compromising therapeutic efficacy, especially in clinical and hospital settings.

Q: What should I do if I miss a dose of Valganciclovir?

A: If you miss a dose, take it as soon as possible. If it is nearly time for your next scheduled dose, skip the missed dose and continue your usual regimen. Do not double up to compensate for a missed dose. Contact your physician if you are unsure.

Tell us about your requirement